French pharma giant Sanofi has bowed to pressure from the French government and vowed to produce over 125 million doses of rivals Pfizer and BioNTech’s Covid-19 vaccine in an extraordinary development in the pharma industry.
Amid a slew of delays and a weak trial showing in December – which cited the need to improve efficacy among older recipients – Sanofi and GlaxoSmithKline will begin phase 2 trials of their own Covid-19 vaccine next month, but do not expect to reach regulatory approval and production phases until the end of 2021.
Continue reading https://on.rt.com/b0el